Concerns growing over adverse effects of co-marketing with multinational firms

There are worries that Korean drug firms’ co-marketing strategy with foreign firms could result in decreasing investments in research and development, which is considered a future growth engine for the country’s pharmaceutical industry.

“The co-marketing or co-promotion strategy to sell original products of multinational firms here may contributed to increasing sales on the part of Korean dr...